Deafness due to orally administered neomycin.
D001299:Audiometry; D002648:Child; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003638:Deafness / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009355:Neomycin / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D012460:Sulfasalazine; D009355:Neomycin; D011241:Prednisone